target price

Solar Pharma: Solar Pharma’s Q2 nos draw value upgrades, inventory hits 7-yr excessive

[ad_1] Mumbai: Higher-than-expected second-quarter earnings by , coupled with a robust commentary, resulted in a pointy upward revision in earnings…

2 years ago